Another Hypotensive Agent--methyldopa

Overview

Journal Br Med J

Specialty General Medicine

Date 1962 Jul 21

PMID 13883201

Citations 10

Authors

D Daley

B Evans

Affiliations

Soon will be listed here.

Citing Articles

Methyldopa for primary hypertension.

Mah G, Tejani A, Musini V Cochrane Database Syst Rev. 2009; (4):CD003893.

PMID: 19821316 PMC: 7154320. DOI: 10.1002/14651858.CD003893.pub3.

METHYLDOPA IN TREATMENT OF HYPERTENSION DUE TO CHRONIC RENAL DISEASE.

Luke R, Kennedy A Br Med J. 1964; 1(5374):27-30.

PMID: 14071629 PMC: 1813017.

Treatment of severe hypertension with methyldopa.

Hamilton M, KOPELMAN H Br Med J. 1963; 1(5324):151-5.

PMID: 13952341 PMC: 2123398. DOI: 10.1136/bmj.1.5324.151.

Parkinsonism occurring with methyldopa treatment.

GRODEN B Br Med J. 1963; 1(5336):1001.

PMID: 13950624 PMC: 2122870. DOI: 10.1136/bmj.1.5336.1001.

Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents).

Vejlsgaard V, Christensen M, Clausen E Br Med J. 1967; 2(5552):598-600.

PMID: 6025595 PMC: 1842098. DOI: 10.1136/bmj.2.5552.598.

References

Sourkes T . Inhibition of dihydroxy-phenylalanine decarboxylase by derivatives of phenylalanine. Arch Biochem Biophys. 1954; 51(2):444-56. DOI: 10.1016/0003-9861(54)90500-7. View

GILLESPIE Jr L, OATES J, CROUT J, SJOERDSMA A . Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension. Circulation. 1962; 25:281-91. DOI: 10.1161/01.cir.25.2.281. View

OATES J, Gillespie L, UDENFRIEND S, SJOERDSMA A . Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine. Science. 1960; 131(3417):1890-1. DOI: 10.1126/science.131.3417.1890. View

Dollery C, Emslie-Smith D, Milne M . Clinical and pharmacological studies with guanethidine in the treatment of hypertension. Lancet. 1960; 2(7147):381-7. DOI: 10.1016/s0140-6736(60)92836-1. View